Related Experiment Video
Updated: Jul 25, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Is elevated blood glucose at admission associated with poor outcomes in hospitalized COVID-19 patients?
Mariana Barbosa1, Juliana Marques-Sá2, Carla Carvalho3
1Serviço de Endocrinologia, Hospital de Braga, Braga, Portugal, marianamb013@gmail.com.
Insights
High blood glucose levels (hyperglycemia) in hospitalized COVID-19 patients indicate a higher risk of severe outcomes and mortality. This association persists even in patients without diabetes, underscoring the importance of glucose monitoring.
Area of Science:
- Endocrinology
- Infectious Diseases
- Critical Care Medicine
Background:
- Hyperglycemia is a potential risk factor for adverse outcomes in coronavirus disease 2019 (COVID-19).
- Understanding the association between blood glucose levels and COVID-19 severity is crucial for patient management.
Purpose of the Study:
- To evaluate the association between blood glucose levels at admission (BGA) and disease outcomes in hospitalized COVID-19 patients.
- To determine if hyperglycemia impacts mortality and severity indicators in COVID-19 patients, including those without diabetes.
Main Methods:
- Retrospective study of 202 adult COVID-19 patients admitted to a Portuguese hospital.
- Patients categorized by blood glucose levels at admission (BGA < 140 mg/dL vs. ≥ 140 mg/dL).
- Statistical analysis performed to compare outcomes between groups, including mortality, mechanical ventilation, and intensive care unit admission.
Main Results:
- Patients with BGA ≥ 140 mg/dL were older, had more comorbidities, and exhibited higher inflammatory markers.
- Hyperglycemia was significantly associated with increased rates of mechanical ventilation, intensive care unit admission, shock, and in-hospital and 30-day mortality.
- Even in non-diabetic patients, hyperglycemia was linked to indicators of severity and poor outcomes, including mortality.
Conclusions:
- Hyperglycemia at admission is a significant predictor of poor outcomes in COVID-19 patients.
- The association between hyperglycemia and adverse outcomes is evident even in patients without pre-existing diabetes.
- Routine glycemic testing is recommended for all COVID-19 patients to identify those at higher risk.
Objective:
Hyperglycemia has been suggested as a risk factor for poor outcomes in coronavirus disease 2019 (COVID-19). The aim of our work was to evaluate the association between blood glucose levels at admission (BGA) and disease outcomes in hospitalized COVID-19 patients.
Subjects And Methods:
Retrospective study including all adult COVID-19 patients admitted to a Portuguese hospital from March to August 2020 with BGA measurement. Subjects were categorized into two groups: BGA < 140 mg/dL and ≥ 140 mg/dL. Statistical analysis was performed using SPSSv26® (significance defined as p < 0.05).
Results:
We included 202 patients: median age 74 (60-86) years; 43.1% female; 31.2% with diabetes. The median BGA was 130.5 (108-158) mg/dL. When compared to normoglycemic, patients with BGA ≥ 140 mg/dL were older (p = 0.013), more vaccinated for influenza (p = 0.025) and had more comorbidities (hypertension, heart failure and peripheral arterial disease, p < 0.05). The last group presented higher leucocyte and neutrophile count, higher procalcitonin and prothrombin time, and lower lymphocyte count. Concerning prognosis, BGA ≥ 140 mg/dL was associated with higher rates of mechanical ventilation requirement and intensive care unit admission (p < 0.001), shock (p = 0.011), in-hospital mortality (p = 0.022) and 30-day mortality (p = 0.037). Considering only non-diabetic patients (n = 139), those with hyperglycemia presented higher rates of severity indicators (polypnea, SatO2 ≤ 93% and PaO2/FiO2 ≤ 300) and an association with poor outcomes was also found, namely mechanical ventilation requirement and in-hospital/30-day mortality (p < 0.05).
Conclusion:
Hyperglycemia at admission was associated with poor outcomes in COVID-19 patients, even in those without known pre-existing diabetes. Glycemic testing should be recommended for all COVID-19 patients.
More Related Videos
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
06:46A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Related Concept Videos
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Diabetes: Symptoms, Diagnosis, and Complications
Hypoglycemia and Glucagon
Diabetes Mellitus: Type 2 and Gestational
Acute Pancreatitis II: Clinical Manifestations and Management
SBAR II: Application of SBAR
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...